Strengthening transparency in randomised trials related to multimorbidity: key points and recommendations to guide reporting.

Wang, Zijun; Burgers, Jako S; Shao, Ruitai; Bian, Zhaoxiang; Wang, Chen; Chen, Yaolong; Estill, Janne

Wang, Zijun; Burgers, Jako S; Shao, Ruitai; Bian, Zhaoxiang; Wang, Chen; Chen, Yaolong; Estill, Janne.

Afiliación

Wang Z; Research Unit of Evidence-Based Evaluation and Guidelines (2021RU017), Chinese Academy of Medical Sciences, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China.
Burgers JS; Institute of Global Health, University of Geneva, Geneve, GE, Switzerland.
Shao R; Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, Limburg, Netherlands.
Bian Z; School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, Beijing, China.
Wang C; China EQUATOR Centre, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, Hong Kong.
Chen Y; School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, Beijing, China.
Estill J; Research Unit of Evidence-Based Evaluation and Guidelines (2021RU017), Chinese Academy of Medical Sciences, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China chevidence@lzu.edu.cn.

BMJ Evid Based Med ; 2024 Jun 05.

Article en En | MEDLINE | ID: mdl-38839262

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: BMJ Evid Based Med / BMJ Evid. Based. Med / BMJ evidence-based medicine (Online) Año: 2024 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google